OM DENNE EPISODE

Engelsk
USA

VIS NOTER 🔗

UDSKRIFT 🔗

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af Biohacking Autism with Nadia Elkhatib..

ANDRE EPISODE I DENNE PODCAST

More than 600 companies are building autism technology, yet most families have never heard of them. This 20-MIN ESSENTIALS edition condenses my conversation with Dan Feshbach, founder of Multiple and co-founder of TeachTown, into the core ideas families need most. Dan and I explore AI for autism,…
A shorter, focused edition of our full John Slattery conversation. Leucovorin, also known as folinic acid, has become one of the most discussed topics in autism research. John Slattery, co-author of the 2018 randomized double-blind placebo-controlled trial of folinic acid in children with autism an…
More than 600 companies are building autism technology, yet most families have never heard of them. What could change if AI, communication tools, sensory technology, and future neurotechnology reached the people who need them? Dan Feshbach, founder of Multiple and co-founder of TeachTown, joins Na…
Leucovorin, also known as folinic acid, has become one of the most discussed topics in autism research. John Slattery, co-author of the 2018 randomized double-blind placebo-controlled trial of folinic acid in children with autism and language impairment, joins Nadia Elkhatib to separate the researc…
What does the brain need to build itself, and why does the answer matter for a child with autism and for the aging brain? In this episode of Biohacking Autism, Nadia Elkhatib talks with Dr. Dayan Goodenowe, PhD, neuroscientist, biochemist and founder of Prodrome Sciences, about autism brain develop…
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Nadia Elkhatib, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.